We are very pleased to introduce you to our new CEO, Diana Zelencova-Gopejenko, Ph.D. Here, we find out a little bit more about Diana, including her medicinal chemistry expertise and how she plans to use her first-hand experience of the whole drug development cycle to both expand Molport’s current offering and introduce new, tailored MedChem tools to make sourcing diverse chemical compounds from around the world easier and faster. By enhancing access to chemical compounds…
9 Key Trends of Medicinal Chemistry from EFMC Rome The landscape of medicinal chemistry is rapidly evolving, driven by groundbreaking research and innovative technologies. As we push the boundaries of what’s possible, new methodologies and targets are emerging that have the potential to revolutionize drug discovery and development. In this post, we’ll delve into some of the most exciting trends from EFMC Rome, from PROTACs and targeted protein degradation to the growing role of green…
